Swiss & Global launches Julius Baer Health Opportunities Fund

Wednesday, 02. March 2011 07:01
Swiss & Global Asset Management /
Swiss & Global launches Julius Baer Health Opportunities Fund
Processed and transmitted by Thomson Reuters.
The issuer is solely responsible for the content of this announcement.

Press release

Zurich, 2 March 2011 - Swiss & Global Asset Management is adding a new fund to
its range of thematic equity products with the launch of the JB Health
Opportunities Fund. The combination of an ageing population, emerging markets
demand and innovation are key drivers for continued growth in the healthcare

The JB Health Opportunities Fund, a UCITS III structure, invests globally in
listed healthcare companies, including emerging-market equities, from all sub-
sectors. This includes producers, distributors and providers of pharmaceuticals,
biotechnology, healthcare services, medical technology and companies active in
the areas of specialty pharmaceuticals and generic drugs.

The portfolio includes between 35 and 45 equities. The fund can have up to 30%
exposure to emerging markets, as social trends in these markets are one of the
crucial drivers of the sector. The fund also invests in traditional
pharmaceutical stocks, many of which are currently trading at depressed
multiples, offer high dividend yields and generate strong cash flows. Another
theme within the portfolio is investment in innovation leaders which focus on
diseases with unmet medical needs.

Nathalie Flury, Co-Portfolio Manager of the JB Health Opportunities Fund, says:
"The global healthcare sector today already accounts for 10-15% of global GDP.
Several powerful, global drivers suggest that the sector should become one of
the major growth markets in the decades to come, creating a compelling
proposition for investors. The chief driver is emerging markets, which exhibit
strong population growth and increasing wealth, which means more people can
afford healthcare.

"A second driver is the fact that the global population is growing older,
leading to increased healthcare spending. Innovation, meanwhile, is driven by
the need for companies to provide ever more targeted therapies for patients
while reducing overall costs. Last but not least, healthcare reform in the US
will lead to more universal health-insurance coverage and an expansion of
healthcare infrastructure."

Christophe Eggmann, Co-Portfolio Manager of the Fund, says: "We combine a growth
and value approach when picking stocks and analyse companies based on both
quantitative and qualitative criteria. This approach enables the fund to capture
the potential arising from developments in the healthcare sector."

Fund data (B shares)

Fund name Julius Baer Multistock - HEALTH OPPORTUNITIES FUND

Launch date 30 September 2010

Domicile Luxembourg

Legal structure SICAV under Luxembourg law

Investment advisor Swiss & Global Asset Management Ltd., Zurich

Base currency USD

Management fee max. 1.60% p.a.

Benchmark MSCI World Healthcare Index

ISIN / Security ID No. LU0529502287 / 11574353

About Swiss & Global Asset Management
Swiss & Global Asset Management is one of the leading dedicated asset managers
in Switzerland and worldwide. At the end of December 2010, Swiss & Global had
client assets under management totalling CHF 80.4 billion and employed more than
250 staff. The company offers a comprehensive range of investment funds,
tailored solutions for institutional clients and customised private labelling
services. Swiss & Global Asset Management is a unique combination of Swiss roots
- in the form of long-standing client relationships and strong quality awareness
- and a network that spans the globe, with more than 1,000 distribution partners
in some 30 countries.

Swiss & Global Asset Management emerged from Julius Baer Asset Management in
October 2009 and is the exclusive manager of Julius Baer funds. Swiss & Global
is a company of the GAM Holding which is listed on the SIX Swiss Exchange. For
more information visit our website at

Important legal information
The information in this document constitutes neither an offer nor investment
advice. It is given for information purposes only.

The Julius Baer Health Opportunities Fund is a sub-fund of Julius Bär Multistock
(SICAV according to Luxembourg law) and it is admitted for public offering and
distribution in Switzerland. Switzerland - Representative: Swiss & Global Asset
Management Ltd., Hohlstrasse 602, P.O.Box, CH-8010 Zurich; Paying Agent: Bank
Julius Baer & Co. Ltd., Bahnhofstrasse 36, Postfach, CH-8010 Zurich. Swiss &
Global Asset Management is not a member of the Julius Baer Group.

Claudia Bally, Media Relations       T +41 58 426 61 08,

--- End of Message ---

Swiss & Global Asset Management
Hohlstrasse 602 Zürich Switzerland

Press release (PDF):

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Swiss & Global Asset Management via Thomson Reuters ONE

Related Links: 
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.